https://pubmed.ncbi.nlm.nih.gov/38091547
This commentary discusses a study evaluating the effectiveness of adjunctive antidepressant maintenance therapy for preventing depressive relapse in patients with bipolar I disorder.
https://pubmed.ncbi.nlm.nih.gov/38091547
This commentary discusses a study evaluating the effectiveness of adjunctive antidepressant maintenance therapy for preventing depressive relapse in patients with bipolar I disorder.
https://pubmed.ncbi.nlm.nih.gov/38091543
The reply by Wharton and Konig discusses the potential benefits and limitations of the GLP-1 receptor agonist Orforglipron for weight management in adults with obesity, as reported in a recent New England Journal of Medicine study.
https://pubmed.ncbi.nlm.nih.gov/38091542
This abstract is a comment on a study published in the New England Journal of Medicine which found that the GLP-1 receptor agonist Orforglipron is effective for weight loss in adults with obesity.
https://pubmed.ncbi.nlm.nih.gov/38091539
This abstract is a comment on a study published in the New England Journal of Medicine that investigated the use of anticoagulation with Edoxaban in patients with atrial high-rate episodes.
https://pubmed.ncbi.nlm.nih.gov/38091538
This study suggests that edoxaban anticoagulation may be a safe and effective option for patients experiencing atrial high-rate episodes, although further research is needed to confirm these findings.